Company / Current Assets per Share
CRESCENT BIOPHARMA, INC. Current Assets per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$232.33
FY2025
5-year range
$2.13 / $232.33
FY2021-FY2025
Trend
+4146.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +4146% YoY in FY2025, a notable deviation from the 4-year average annual change of +1049%.
Based on SEC 10-K filings.
232.33 in FY2025 with a 10-year CAGR of +57.4%.
Improved from $2.13 to $232.33 over the past 9 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +57.4%
Key checks
Key Insights
- In FY2025, current assets per share increased 4146.0% year-over-year.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $232.33 | +4146.0% |
| FY2017 | $5.47 | +157.3% |
| FY2016 | $2.13 | -14.7% |
| FY2015 | $2.49 | -93.7% |
| FY2014 | $39.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026